CD36 deficiency rescues lipotoxic cardiomyopathy - PubMed (original) (raw)
Comparative Study
. 2007 Apr 27;100(8):1208-17.
doi: 10.1161/01.RES.0000264104.25265.b6. Epub 2007 Mar 15.
Affiliations
- PMID: 17363697
- DOI: 10.1161/01.RES.0000264104.25265.b6
Comparative Study
CD36 deficiency rescues lipotoxic cardiomyopathy
John Yang et al. Circ Res. 2007.
Abstract
Obesity-related diabetes mellitus leads to increased myocardial uptake of fatty acids (FAs), resulting in a form of cardiac dysfunction referred to as lipotoxic cardiomyopathy. We have shown previously that chronic activation of the FA-activated nuclear receptor, peroxisome proliferator-activated receptor alpha (PPARalpha), is sufficient to drive the metabolic and functional abnormalities of the diabetic heart. Mice with cardiac-restricted overexpression of PPARalpha (myosin heavy chain [MHC]-PPARalpha) exhibit myocyte lipid accumulation and cardiac dysfunction. We sought to define the role of the long-chain FA transporter CD36 in the pathophysiology of lipotoxic forms of cardiomyopathy. MHC-PPARalpha mice were crossed with CD36-deficient mice (MHC-PPARalpha/CD36-/- mice). The absence of CD36 prevented myocyte triacylglyceride accumulation and cardiac dysfunction in the MHC-PPARalpha mice under basal conditions and following administration of high-fat diet. Surprisingly, the rescue of the MHC-PPARalpha phenotype by CD36 deficiency was associated with increased glucose uptake and oxidation rather than changes in FA utilization. As predicted by the metabolic changes, the activation of PPARalpha target genes involved in myocardial FA-oxidation pathways in the hearts of the MHC-PPARalpha mice was unchanged in the CD36-deficient background. However, PPARalpha-mediated suppression of genes involved in glucose uptake and oxidation was reversed in the MHC-PPARalpha/ CD36-/- mice. We conclude that CD36 is necessary for the development of lipotoxic cardiomyopathy in MHC-PPARalpha mice and that novel therapeutic strategies aimed at reducing CD36-mediated FA uptake show promise for the prevention or treatment of cardiac dysfunction related to obesity and diabetes.
Comment in
- Therapeutic challenge to adiposity of the heart.
Osanai T, Okumura K. Osanai T, et al. Circ Res. 2007 Apr 27;100(8):1106-8. doi: 10.1161/01.RES.0000266975.34924.b1. Circ Res. 2007. PMID: 17463325 No abstract available.
Similar articles
- Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
Duncan JG, Bharadwaj KG, Fong JL, Mitra R, Sambandam N, Courtois MR, Lavine KJ, Goldberg IJ, Kelly DP. Duncan JG, et al. Circulation. 2010 Jan 26;121(3):426-35. doi: 10.1161/CIRCULATIONAHA.109.888735. Epub 2010 Jan 11. Circulation. 2010. PMID: 20065164 Free PMC article. - Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice.
Chen W, Chen W, Xia Y, Zhao X, Wang H, Yu M, Li Y, Ye H, Zhang Y. Chen W, et al. Mol Biol Rep. 2013 Mar;40(3):2449-59. doi: 10.1007/s11033-012-2325-1. Epub 2012 Nov 30. Mol Biol Rep. 2013. PMID: 23196711 - The critical role of Astragalus polysaccharides for the improvement of PPARα [ correction of PPRAα]-mediated lipotoxicity in diabetic cardiomyopathy.
Chen W, Xia Y, Zhao X, Wang H, Chen W, Yu M, Li Y, Ye H, Zhang Y. Chen W, et al. PLoS One. 2012;7(10):e45541. doi: 10.1371/journal.pone.0045541. Epub 2012 Oct 1. PLoS One. 2012. PMID: 23049681 Free PMC article. - High fat diet induced diabetic cardiomyopathy.
Dirkx E, Schwenk RW, Glatz JF, Luiken JJ, van Eys GJ. Dirkx E, et al. Prostaglandins Leukot Essent Fatty Acids. 2011 Nov;85(5):219-25. doi: 10.1016/j.plefa.2011.04.018. Epub 2011 May 14. Prostaglandins Leukot Essent Fatty Acids. 2011. PMID: 21571515 Review. - From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid uptake.
Glatz JF, Luiken JJ. Glatz JF, et al. Biochimie. 2017 May;136:21-26. doi: 10.1016/j.biochi.2016.12.007. Epub 2016 Dec 22. Biochimie. 2017. PMID: 28013071 Review.
Cited by
- Endothelial Dysfunction in Obesity and Therapeutic Targets.
Engin A. Engin A. Adv Exp Med Biol. 2024;1460:489-538. doi: 10.1007/978-3-031-63657-8_17. Adv Exp Med Biol. 2024. PMID: 39287863 Review. - Specific Compounds Derived from Traditional Chinese Medicine Ameliorate Lipid-Induced Contractile Dysfunction in Cardiomyocytes.
Wang F, Neumann D, Kapsokalyvas D, Hoes MF, Schianchi F, Glatz JFC, Nabben M, Luiken JJFP. Wang F, et al. Int J Mol Sci. 2024 Jul 25;25(15):8131. doi: 10.3390/ijms25158131. Int J Mol Sci. 2024. PMID: 39125700 Free PMC article. - Mitochondrial glycerol 3-phosphate dehydrogenase deficiency exacerbates lipotoxic cardiomyopathy.
Qu H, Liu X, Zhu J, He N, He Q, Zhang L, Wang Y, Gong X, Xiong X, Liu J, Wang C, Yang G, Yang Q, Luo G, Zhu Z, Zheng Y, Zheng H. Qu H, et al. iScience. 2024 May 11;27(6):109796. doi: 10.1016/j.isci.2024.109796. eCollection 2024 Jun 21. iScience. 2024. PMID: 38832016 Free PMC article. - UCP1-dependent brown adipose activation accelerates cardiac metabolic remodeling and reduces initial hypertrophic and fibrotic responses to pathological stress.
Challa AA, Vidal P, Maurya SK, Maurya CK, Baer LA, Wang Y, James NM, Pardeshi PJ, Fasano M, Carley AN, Stanford KI, Lewandowski ED. Challa AA, et al. FASEB J. 2024 Jun 15;38(11):e23709. doi: 10.1096/fj.202400922R. FASEB J. 2024. PMID: 38809700 - Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
Heather LC, Gopal K, Srnic N, Ussher JR. Heather LC, et al. Diabetes. 2024 May 1;73(5):659-670. doi: 10.2337/dbi23-0019. Diabetes. 2024. PMID: 38387045 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- P01 HL57278/HL/NHLBI NIH HHS/United States
- P30 DK056341/DK/NIDDK NIH HHS/United States
- P30 DK056341-07/DK/NIDDK NIH HHS/United States
- P30 DK56341/DK/NIDDK NIH HHS/United States
- P30 DK056341-06/DK/NIDDK NIH HHS/United States
- P50 HL077113/HL/NHLBI NIH HHS/United States
- P30 DK52574/DK/NIDDK NIH HHS/United States
- KO8 HL076452/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous